Study Stomach-shrinking bariatric surgery treatment
WASHINGTON: Stomach-shrinking bariatric surgery beats other forms of treatment in bringing about remission of type 2 diabetes in the obese, according to a Swedish study out Tuesday.
The study, to appear in Wednesday´s issue of the Journal of the American Medical Association (JAMA), also found that the procedure was linked to fewer diabetes-related complications in the severely overweight. The findings come at a time when obesity and diabetes have reached epidemic proportions, creating a costly public health problem.
In the United States, more than 29 million people — or 9.3 percent of the population — had diabetes in 2012, up from an estimated 26 million two years earlier, the Centers for Disease Control and Prevention said Tuesday.
Treating the disease and related complications amounted to $245 billion in medical expenses, as well as lost pay in 2012, up from $174 billion five years earlier.
Carried out by a team led by Lars Sjostrom of the University of Gothenburg, the findings to appear in JAMA involved a follow-up of the Swedish Obese Subjects study.
The median follow-up time was 18.1 years for people who had had surgery and 17.6 years in the control group in an effort to determine the long-term effects of bariatric procedures, diabetes remission and diabetes-linked complications.